Press-release for stocks for BLUE

Prices are updated after-hours

TCR² Therapeutics Appoints Cell & Gene Therapy Manufacturing Veteran Peter Olagunju as Chief Technical Officer
Published: 2021-07-20 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M

| -89.41% | O: 0.07% H: 3.43% C: 3.22%
BLUE | $0.9583 -0.52% -0.52% 6.5M

| -96.43% | O: -0.53% H: 3.74% C: 3.13%
gene therapy therapy gene therapies

64%

36%

AGBA | News | $1.02 155.0% 57.94% 120M

ZCMD | $2.86 108.76% 52.1% 2.3M

INVO | $1.555 104.6% 51.13% 5M

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M

GGE | $0.035 19.86% 29.3% 64M

Save your searches and get alerts when important news are released.